| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥10521.9B | ¥10711.3B | -1.8% |
| Operating Income | ¥521.9B | ¥445.2B | +17.2% |
| Ordinary Income | ¥442.5B | ¥379.1B | +16.7% |
| Net Income | ¥197.1B | ¥361.8B | -45.5% |
| ROE | 4.0% | 8.6% | - |
FY2025 consolidated results: Revenue of 1,052.19B yen declined 1.8% YoY, while operating income improved significantly to 52.19B yen (+17.2% YoY), representing an operating margin of 5.0% (up from 4.2% prior year). Ordinary income reached 44.25B yen (+16.7%), and net income attributable to owners totaled 32.35B yen (+51.8% YoY), though reported net income was 19.71B yen (-45.5%) due to accounting treatment differences. The profit improvement occurred despite revenue contraction, driven by cost management and operational efficiency gains. Operating cash flow surged 57.9% to 72.97B yen, demonstrating strong cash generation capability. ROE improved to 6.6% (calculated: 3.1% net margin × 0.826 asset turnover × 2.60 leverage), supported primarily by enhanced profitability. Financial position strengthened with significant debt reduction: short-term borrowings decreased 75.1% to 6.66B yen and long-term debt fell 28.4% to 198.91B yen, resulting in a healthy Debt/EBITDA ratio of 1.94x. The company guides FY2026 revenue of 1,100B yen (+4.5%) and operating income of 56B yen (+7.3%), indicating expectations for continued recovery and margin expansion.
Revenue declined 1.8% to 1,052.19B yen from 1,071.13B yen, reflecting challenging market conditions across key segments. Packaging & Graphic, the largest segment at 54.96B yen sales (50.5% of total), decreased 1.9% YoY but delivered operating income of 31.08B yen with a 5.7% margin. Functional Products generated 290.85B yen revenue (down 1.9% YoY) with the highest operating margin at 7.9% (23.11B yen operating income). Color & Display contributed 247.47B yen sales (down 1.2% YoY) with operating income of 4.99B yen (2.0% margin), showing recovery from prior year's operating loss of 0.27B yen. Gross profit reached 227.97B yen with a 21.7% gross margin (down from 222.20B yen and 20.7% margin prior year), indicating improved pricing power or product mix despite revenue decline. SG&A expenses decreased to 175.78B yen (16.7% of revenue) from 177.68B yen, contributing to operating leverage improvement. The 17.2% operating income growth was driven by cost rationalization, with corporate overhead reducing from 8.59B yen to 7.24B yen. Non-operating items created a gap between operating income (52.19B yen) and ordinary income (44.25B yen), primarily due to net non-operating expenses of 7.94B yen including interest expense of 6.34B yen and foreign exchange losses of 5.12B yen, partially offset by equity method income of 3.87B yen and interest/dividend income of 2.81B yen. Extraordinary items contributed significantly: extraordinary income of 14.67B yen (including gain on asset sales of 1.20B yen and securities sales of 0.59B yen) exceeded extraordinary losses of 7.29B yen (impairment loss of 1.26B yen), adding 7.38B yen to pre-tax profit. The divergence between net income attributable to owners (32.35B yen, +51.8%) and reported net income (19.71B yen, -45.5%) reflects different accounting consolidation treatment. Comprehensive income expanded substantially to 80.12B yen (from 46.28B yen prior year) driven by other comprehensive income of 46.91B yen, including foreign currency translation adjustments of 27.05B yen and remeasurements of defined benefit plans of 17.49B yen, indicating significant unrealized gains from overseas operations and pension obligations. This represents a revenue down/profit up pattern, achieved through operational efficiency gains and cost discipline offsetting top-line pressure.
Packaging & Graphic serves as the core business, accounting for 52.2% of total revenue at 549.68B yen with operating income of 31.08B yen (5.7% margin). This segment manufactures gravure inks, offset inks, newspaper inks, jet inks, and polystyrene products. While revenue declined modestly, profitability remained stable with slight margin compression from 5.6% to 5.7%. Color & Display generated 247.47B yen revenue with operating income of 4.99B yen (2.0% margin), showing dramatic improvement from prior year's operating loss, primarily through pigments and healthcare food products. This segment demonstrates the most significant turnaround performance. Functional Products produced 290.85B yen revenue with the highest profitability at 23.11B yen operating income (7.9% margin, down slightly from 7.2% prior year), encompassing acrylic resins, urethane resins, epoxy resins, PPS compounds, and industrial tapes. This segment exhibits superior value-added positioning. Material margin differences are significant: Functional Products' 7.9% margin exceeds Color & Display's 2.0% by 5.9 percentage points and Packaging & Graphic's 5.7% by 2.2 percentage points, indicating substantial variance in competitive positioning and pricing power across business portfolios. Management reorganization consolidated certain subsidiaries from Packaging & Graphic to Functional Products, affecting period comparability but prior period figures have been restated for consistency.
[Profitability] ROE of 6.6% reflects improvement from prior period's 5.6%, driven by enhanced net margin (3.1%) rather than asset turnover (0.826) or leverage (2.60x). Operating margin expanded to 5.0% from 4.2%, representing an 80 basis point improvement despite revenue decline, demonstrating operational efficiency gains. Gross margin strengthened to 21.7% from 20.7%. EBIT margin stands at 5.0% with EBITDA margin calculated at approximately 10.1% (including depreciation of 53.84B yen). Basic EPS improved substantially to 341.71 yen from 225.11 yen (+51.8%), outpacing net income growth due to steady share count. [Cash Quality] Cash and deposits total 68.91B yen, providing 10.34x coverage of short-term debt (6.66B yen), indicating substantial liquidity buffer. Operating cash flow of 72.97B yen represents 226% of reported net income and 370% coverage of capital expenditures (41.65B yen), confirming cash-backed earnings quality. However, operating CF to EBITDA conversion ratio of 0.69 falls below the healthy threshold of 1.0, indicating working capital efficiency challenges. Days Sales Outstanding (DSO) extends to approximately 80 days (accounts receivable 231.45B yen / daily sales 2.88B yen), and Days Inventory Outstanding (DIO) reaches 132 days (inventory 189.30B yen / daily COGS 22.59B yen), suggesting room for working capital optimization. [Investment Efficiency] Total asset turnover of 0.826 reflects moderate asset utilization. Fixed asset turnover stands at approximately 2.84 (revenue / PP&E of 371.09B yen). R&D expenditure of 15.96B yen represents only 1.5% of revenue, which appears modest for a specialty materials company and may warrant monitoring for long-term competitive positioning. CapEx of 41.65B yen relative to depreciation of 53.84B yen yields a CapEx-to-depreciation ratio of 0.77, indicating maintenance-level investment with limited growth capital deployment. [Financial Health] Equity ratio strengthens to 38.5% (shareholders' equity 490.84B yen / total assets 1,274.09B yen) from 34.3%, reflecting balance sheet improvement. Current ratio stands at 162.3% (current assets 627.55B yen / current liabilities 386.55B yen) and quick ratio at 113.4%, both indicating healthy liquidity. Debt-to-equity ratio improves to 0.42 (interest-bearing debt of 205.57B yen / total equity 490.84B yen). Net debt position totals 136.66B yen (gross debt minus cash), yielding net debt-to-EBITDA of 1.29x. Interest coverage ratio (EBITDA / interest expense) reaches 16.73x, demonstrating comfortable debt servicing capacity.
Operating cash flow of 72.97B yen represents a substantial 57.9% increase YoY, with operating CF before working capital changes of 88.13B yen demonstrating strong underlying cash generation. The operating CF to reported net income ratio of 3.70 confirms high-quality earnings, though operating CF to net income attributable to owners ratio of 2.26 also indicates solid conversion. Cash conversion efficiency shows mixed signals: while OCF robustly covers net income, the OCF-to-EBITDA ratio of 0.69 falls short of the ideal 1.0+ threshold, primarily due to working capital absorption. Inventory increased 3.15B yen, accounts receivable decreased 6.77B yen (improving working capital), but accounts payable decreased 11.42B yen (consuming cash), resulting in net working capital cash usage. Income taxes paid of 15.93B yen and interest paid of 6.18B yen represented 21.8% and 8.5% of operating cash flow respectively. Investing cash flow of negative 20.59B yen was dominated by CapEx of 41.65B yen, partially offset by proceeds from asset sales of 4.64B yen and disposal of intangibles of 4.12B yen. The resulting free cash flow of 52.38B yen (operating CF plus investing CF) provides 5.50x coverage of dividends paid (9.50B yen), indicating substantial shareholder return capacity. Financing cash flow of negative 45.39B yen reflects aggressive debt reduction strategy: long-term loan repayments of 55.94B yen and bond redemptions of 10B yen, partially funded by new long-term borrowings of 4.08B yen and bond issuance of 1.50B yen, resulting in net debt repayment of 60.42B yen. This deleveraging activity, combined with dividends of 9.50B yen and negligible treasury stock transactions, demonstrates commitment to balance sheet strengthening. Cash position increased 6.37B yen during the period to 67.31B yen after adjusting for foreign exchange effects of negative 0.62B yen, with cash-to-short-term liabilities coverage of 17.4% indicating adequate but not excessive liquidity positioning.
Ordinary income of 44.25B yen versus operating income of 52.19B yen indicates net non-operating expenses of approximately 7.94B yen. Non-operating income of 8.56B yen comprises primarily equity method investment income of 3.87B yen, interest income of 2.81B yen, and dividend income of 0.27B yen. Non-operating expenses of 16.50B yen include interest expense of 6.34B yen, foreign exchange losses of 5.12B yen, and other non-operating expenses of 5.04B yen. Net non-operating items represent 0.75% of revenue, a relatively modest impact dominated by structural items (interest expense) and volatile items (FX losses). Extraordinary items contributed net 7.38B yen to pre-tax profit, with extraordinary income of 14.67B yen (including asset disposal gains of 1.20B yen, investment securities gains of 0.59B yen, and insurance income of 1.17B yen) exceeding extraordinary losses of 7.29B yen (impairment losses of 1.26B yen, asset disposal losses of 2.13B yen, business exit costs of 0.49B yen, and subsidiary liquidation losses of 0.32B yen). These extraordinary items represent 1.4% of revenue and constitute non-recurring factors that artificially enhanced reported profitability. Operating cash flow of 72.97B yen substantially exceeds reported net income of 19.71B yen and net income attributable to owners of 32.35B yen, indicating healthy underlying earnings quality with strong cash realization. However, the OCF-to-EBITDA ratio of 0.69 suggests working capital intensity, primarily driven by elevated inventory (189.30B yen) and receivables (231.45B yen) relative to revenue scale. Comprehensive income of 80.12B yen far exceeds net income due to other comprehensive income of 46.91B yen, mainly from unrealized translation gains (27.05B yen) and pension remeasurement gains (17.49B yen), representing economic value changes not reflected in P&L. The significant gap between comprehensive income and net income highlights the importance of monitoring both realized and unrealized gains for complete performance assessment.
Full-year guidance projects revenue of 1,100B yen (FY2026), operating income of 56B yen, and ordinary income of 48B yen. Current period results show revenue achievement rate of 95.7% (1,052.19B yen actual / 1,100B yen guidance), operating income achievement of 93.2% (52.19B yen / 56B yen), and ordinary income achievement of 92.2% (44.25B yen / 48B yen). These progress rates suggest the company is slightly trailing its full-year targets, though given these appear to be FY2026 forward guidance rather than FY2025 targets, the comparison indicates FY2025 actual results form a solid baseline for achieving modest growth targets. The guidance implies YoY growth expectations of revenue +4.5%, operating income +7.3%, and ordinary income +8.5%, with forecasted EPS of 348.54 yen and annual dividend of 70 yen per share. Key assumptions underlying forecasts include continued operational efficiency gains to drive margin expansion despite modest revenue growth, stabilization of foreign exchange impacts currently creating headwinds (5.12B yen FX losses in current period), and successful execution of product mix improvements toward higher-margin Functional Products segment. The conservative revenue growth assumption (+4.5%) appears realistic given current period's 1.8% decline, suggesting management expects gradual market recovery rather than dramatic rebound. Operating income growth outpacing revenue growth (+7.3% vs +4.5%) indicates continued focus on operational leverage and cost discipline. Management commentary notes these projections are based on currently available information and reasonable assumptions, with actual results subject to variation from multiple factors including raw material prices, foreign exchange rates, and customer demand dynamics.
Annual dividend totals 100 yen per share (50 yen interim + 50 yen year-end), compared to prior year's 50 yen per share, representing a 100% YoY increase in dividend payment. Based on reported net income of 19.71B yen and total dividends paid of 9.50B yen, the payout ratio reaches 48.2%. However, using net income attributable to owners of 32.35B yen yields a more meaningful payout ratio of 29.4% (9.50B yen dividends / 32.35B yen). Average shares outstanding of 94.68M shares result in calculated total dividend payment of 9.47B yen, closely matching actual cash dividends paid of 9.50B yen. Share buyback activity was minimal at 0.06B yen of treasury stock purchases, resulting in a total return ratio of approximately 29.7% (dividends plus buybacks divided by net income attributable to owners). Free cash flow of 52.38B yen provides 5.50x coverage of dividends, indicating strong sustainability. The company guides a FY2026 annual dividend of 70 yen per share, implying dividend reduction from the current 100 yen level but still representing growth from the prior year's 50 yen base. Based on forecasted EPS of 348.54 yen, the projected 70 yen dividend yields a forward payout ratio of 20.1%, suggesting conservative and sustainable dividend policy with ample retained earnings for growth investment and balance sheet management.
Revenue concentration risk: Packaging & Graphic segment represents 52.2% of total sales at 549.68B yen, creating significant exposure to printing and packaging industry dynamics. Any structural decline in traditional printing demand or customer consolidation could materially impact overall performance. Operating margin sensitivity: Current operating margin of 5.0% remains modest relative to specialty chemical industry benchmarks, with limited buffer against cost pressures. Raw material price volatility or inability to pass through cost increases could rapidly compress profitability, particularly given the company's 78.3% cost of sales ratio. Working capital efficiency challenges: Elevated DSO of approximately 80 days and DIO of 132 days indicate cash conversion cycle inefficiencies. Inventories totaling 189.30B yen (18.0% of revenue) and accounts receivable of 231.45B yen (22.0% of revenue) represent substantial capital tied up in operations. Failure to optimize working capital management could constrain cash generation and limit financial flexibility. Foreign exchange exposure amplifies earnings volatility: Current period FX losses of 5.12B yen demonstrate meaningful sensitivity to currency movements. With significant overseas operations reflected in comprehensive income's 27.05B yen translation adjustment, exchange rate fluctuations create both P&L and equity impacts that complicate performance assessment and financial planning.
[Industry Position] (Reference - Proprietary Analysis)
The specialty chemicals and materials sector demonstrates wide performance dispersion. DIC's operating margin of 5.0% positions below industry median performers, though improving trajectory from prior year's 4.2% indicates operational progress. The company's ROE of 6.6% compares to industry median ranges typically in the 7-10% zone for established chemical companies, suggesting moderate but improving profitability relative to capital employed. Financial health metrics appear solid: equity ratio of 38.5% aligns with industry median standards of 35-45% for capital-intensive chemical manufacturers, indicating appropriate balance sheet structure. Net debt-to-EBITDA of 1.29x positions comfortably below industry leverage norms of 2.0-2.5x, demonstrating conservative financial management. Interest coverage of 16.73x substantially exceeds industry median of 5-8x, reflecting low financial risk profile. Working capital intensity presents a relative disadvantage: DIC's DSO of 80 days and DIO of 132 days appear extended compared to more efficient specialty chemical peers operating in the 60-70 day DSO and 90-110 day DIO ranges. Cash conversion efficiency (OCF/EBITDA of 0.69) trails industry best practices of 0.85-1.0, primarily due to working capital drag. R&D intensity of 1.5% falls below industry median of 2.5-4.0% for specialty chemical companies, potentially limiting long-term differentiation capability. DIC occupies a mid-tier position within Japanese specialty chemical manufacturers, demonstrating solid financial fundamentals but facing profitability and efficiency challenges relative to global best-in-class peers. The company's diversified segment structure provides portfolio balance, though concentration in mature printing materials creates structural headwinds not faced by firms more heavily exposed to electronic materials or advanced functional products.
(Reference - Proprietary Analysis of specialty chemicals industry, comparison based on prior fiscal periods, source: Proprietary analysis)
Operational turnaround demonstrates traction: The achievement of 17.2% operating income growth despite 1.8% revenue decline validates management's cost discipline and efficiency initiatives. Operating margin expansion from 4.2% to 5.0% combined with SG&A ratio improvement from 16.6% to 16.7% demonstrates operating leverage realization. However, absolute margin levels remain modest, indicating substantial further improvement potential required to reach peer-competitive profitability. Balance sheet transformation strengthens financial foundation: Aggressive debt reduction totaling 60.42B yen net repayment, combined with equity ratio improvement to 38.5%, positions the company with enhanced financial flexibility. Debt-to-EBITDA declining to 1.94x gross (1.29x net) and interest coverage expanding to 16.73x create capacity for strategic investments or shareholder returns. The shift from heavily indebted structure toward conservatively capitalized position marks a significant strategic accomplishment. Working capital optimization represents critical next-phase opportunity: Elevated DSO and DIO consuming approximately 212 days of working capital cycle compared to potential best-practice of 160-180 days suggests 50-70B yen of cash could theoretically be released through receivables acceleration and inventory reduction. The 0.69 OCF/EBITDA ratio indicates working capital improvements could drive meaningful cash generation enhancement without requiring revenue growth or margin expansion. Portfolio rebalancing toward higher-value segments shows early progress: Functional Products' 7.9% operating margin substantially exceeds corporate average, while Color & Display's recovery from operating loss to 2.0% margin demonstrates turnaround capability. However, Packaging & Graphic's ongoing dominance at 52% of revenue in a structurally challenged printing industry requires strategic repositioning toward electronic materials, advanced polymers, or other growth domains to sustain long-term competitive positioning.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.